DOI QR코드

DOI QR Code

Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography

  • Zheng, Jianjun (Department of Radiology, Ningbo N.2 Hospital) ;
  • Wang, Jing (Imaging Center, First Teaching Hospital, Xinjiang Medical University) ;
  • Zhao, Jianqing (Imaging Center, First Teaching Hospital, Xinjiang Medical University) ;
  • Meng, Xianyun (Department of Radiology, Ningbo N.2 Hospital)
  • Received : 2017.01.22
  • Accepted : 2017.04.19
  • Published : 2018.02.01

Abstract

Objective: More than 70% of hepatic alveolar echinococcosis (HAE) are inoperable. Thus, long-term, or even life-long, pharmacological treatment with benzimidazoles is necessary. For effective treatment, it is of great importance to employ imaging techniques to detect and monitor the non-resectable parasitic viability. Therefore, this study aimed to evaluate diffusion-weighted imaging (DWI) in assessing the viability of HAE in comparison to 18-fluoro-deoxyglucose (18F-FDG) positron emission tomography, combined with computed tomography (PET/CT). Materials and Methods: Positron emission tomography, computed tomography and DWI (b-values: 0, $800s/mm^2$) were retrospectively analysed in eight patients with clinically-verified HAE to, generate the apparent diffusion coefficient (ADC) map. The activity of HAE lesions in both techniques were determined independently by two radiologists according to the following standard: (+), marked focally or perilesionally increased FDG uptake/high signal intensity; (-), a hepatic defect without FDG uptake/no high signal intensity. Every lesion's maximum standardized uptake value ($SUV_{max}$) on the PET/CT images and mean ADC values on the parametric ADC maps were measured respectively. Results of PET/CT and DWI were compared on a per-lesion-basis. Pearson's correlation coefficient was assessed for statistical analysis. Results: A total of 14 HAE lesions were detected. Eight lesions (diameter 3-15 cm) showed perilesional hyper-signal intensity on DWI. This was visualised on PET/CT as increased FDG uptake. They mainly existed in the lesion's border with normal liver parenchyma. Five lesions (diameter < 2 cm) were detected as nodular hyperintensity on DWI and a 'hot spot' on PET/CT in the same distribution. One patient, who had received oral drug therapy for three years showed significantly decreased perilesional hyperintensity on the DWI and a hepatic defect without any FDG uptake on PET/CT. Pearson's correlation coefficient indicated a significant inverse correlation of the ADC and the $SUV_{max}$ (r = -0.67, p < 0.001). Conclusion: Diffusion-weighted imaging is capable of offering information on visually detecting the HAE lesions' viability and may be useful for routine application in the initial diagnosis of HAE.

Keywords

Acknowledgement

Supported by : National Natural Science Foundation of China

References

  1. Brunetti E, Kern P, Vuitton DA; Writing Panel for the WHOIWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010;114:1-16 https://doi.org/10.1016/j.actatropica.2009.11.001
  2. Buttenschoen K, Carli Buttenschoen D, Gruener B, Kern P, Beger HG, Henne-Bruns D, et al. Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg 2009;394:689-698 https://doi.org/10.1007/s00423-008-0392-5
  3. Crouzet J, Grenouillet F, Delabrousse E, Blagosklonov O, Thevenot T, Di Martino V, et al. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emissiontomography combined with serological and computed tomography follow-up. Clin Microbiol Infect 2010;16:788-791 https://doi.org/10.1111/j.1469-0691.2009.02924.x
  4. Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis 1999;29:1157-1163 https://doi.org/10.1086/313438
  5. Kim H, Lee JM, Yoon JH, Jang JY, Kim SW, Ryu JK, et al. Reduced field-of-view diffusion-weighted magnetic resonance imaging of the pancreas: comparison with conventional single-shot echo-planar imaging. Korean J Radiol 2015;16:1216-1225 https://doi.org/10.3348/kjr.2015.16.6.1216
  6. Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, et al. Diffusion-weighted MR imaging in comparison to integrated [$^{18}F$]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol 2012;81:178-182 https://doi.org/10.1016/j.ejrad.2010.09.001
  7. Kantarci M, Bayraktutan U, Karabulut N, Aydinli B, Ogul H, Yuce I, et al. Alveolar echinococcosis: spectrum of findings at cross-sectional imaging. Radiographics 2012;32:2053-2070 https://doi.org/10.1148/rg.327125708
  8. Kodama Y, Fujita N, Shimizu T, Endo H, Nambu T, Sato N, et al. Alveolar echinococcosis: MR findings in the liver. Radiology 2003;228:172-177 https://doi.org/10.1148/radiol.2281020323
  9. Becce F, Pomoni A, Uldry E, Halkic N, Yan P, Meuli R, et al. Alveolar echinococcosis of the liver: diffusion-weighted MRI findings and potential role in lesion characterisation. Eur J Radiol 2014;83:625-631 https://doi.org/10.1016/j.ejrad.2013.12.025
  10. Ahn JH, Yu JS, Cho ES, Chung JJ, Kim JH, Kim KW. Diffusionweighted MRI of malignant versus benign portal vein thrombosis. Korean J Radiol 2016;17:533-540 https://doi.org/10.3348/kjr.2016.17.4.533
  11. Culverwell AD, Sheridan MB, Guthrie JA, Scarsbrook AF. Diffusion-weighted MRI of the liver-Interpretative pearls and pitfalls. Clin Radiol 2013;68:406-414 https://doi.org/10.1016/j.crad.2012.08.008
  12. Lin C, Itti E, Luciani A, Zegai B, Lin SJ, Kuhnowski F, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 2011;46:341-349
  13. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, et al. F-18-fluorodeoxyglucose (FDG) positronemission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 2007;35:11-18 https://doi.org/10.1007/s15010-007-6133-9
  14. Vuitton DA, Gottstein B. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. J Biomed Biotechnol 2010;2010:923193
  15. Regier M, Derlin T, Schwarz D, Laqmani A, Henes FO, Groth M, et al. Diffusion weighted MRI and 18F-FDG PET/CT in nonsmall cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)? Eur J Radiol 2012;81:2913-2918 https://doi.org/10.1016/j.ejrad.2011.11.050
  16. Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, et al. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med 2013;54:358-363 https://doi.org/10.2967/jnumed.112.109942

Cited by

  1. The spectrum of multimodality imaging findings in hepatic alveolar echinococcosis and the potential role of diffusion-weighted imaging in its characterisation vol.85, pp.1, 2020, https://doi.org/10.5114/pjr.2020.101015
  2. Hepatic alveolar echinococcosis: correlation between computed tomography morphology and inflammatory activity in positron emission tomography vol.10, pp.None, 2018, https://doi.org/10.1038/s41598-020-68624-9
  3. Hepatic Alveolar Echinococcosis: Predictive Biological Activity Based on Radiomics of MRI vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/6681092
  4. Quantitative evaluation of range and metabolic activity of hepatic alveolar echinococcosis lesion microenvironment using PET/CT and multi-site sampling method vol.21, pp.1, 2018, https://doi.org/10.1186/s12879-021-06366-3